Enrolling by invitationNCT06101940
A Multicenter Phenotype-Genotype Analysis of DM1 Patients in China
Studying Myotonic dystrophy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Huashan Hospital
- Principal Investigator
- Chongbo Zhao, PhDHuashan Hospital
- Intervention
- MRI scan(diagnostic_test)
- Enrollment
- 500 enrolled
- Eligibility
- 18-80 years · All sexes
- Timeline
- 2021 – 2032
Study locations (22)
- Chinese People's Liberation Army General Hospital, Beijing, Beijing Municipality, China
- Peking University First Hospital, Beijing, Beijing Municipality, China
- First Affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing Municipality, China
- Fujian Medical University Union Hospital, Fuzhou, Fujian, China
- Southern Hospital of Southern Medical University, Guangzhou, Guangdong, China
- The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
- Wuhan University People's Hospital, Wuhan, Hubei, China
- Zhongda Hospital Southeast University, Nanjing, Jiangsu, China
- The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
- The First People's Hospital of Yancheng, Yancheng, Jiangsu, China
- The First Affiliated Hospital of Nanchang University）, Nanchang, Jiangxi, China
- The First Bethune Hospital of Jilin University, Changchun, Jilin, China
- Chifeng Municipal Hospital, Chifeng, Neimenggu, China
- Qilu Hospital of Shandong University, Jinan, Shandong, China
- Children's Hospital of Fudan University, Shanghai, Shanghai Municipality, China
- +7 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06101940 on ClinicalTrials.govOther trials for Myotonic dystrophy
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT07486934Efficacy, Safety, and Tolerability of DYNE-101 in Participants With Myotonic Dystrophy Type 1Dyne Therapeutics
- RECRUITINGPHASE2NCT07220603An Open-Label Extension Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1 (FREEDOM-OLE)PepGen Inc
- ACTIVE NOT RECRUITINGNCT07493525Fall Frequency and Factors Affecting Dynamic Balance in Patients With Myotonic Dystrophy Type 1Antalya Training and Research Hospital
- RECRUITINGNCT06747884Trial Readiness and Endpoint Assessment in Pediatric Myotonic Dystrophy ExtensionVirginia Commonwealth University
- RECRUITINGNCT07385443The Spanish National Registry for Myotonic Dystrophy Type 1Fundació Institut Germans Trias i Pujol
- RECRUITINGNCT07362875Development of Quantitative Muscle Imaging as a Biomarker of Disease Endpoints in Myotonic DystrophyWake Forest University Health Sciences
- RECRUITINGNANCT06809049Music Intervention for Brain-Heart Disease in Myotonic Dystrophy Type 1 (DM1)Hanns Lochmuller
- RECRUITINGPHASE2NCT06667453A Clinical Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1PepGen Inc